[Skip to Navigation]
January 6, 2020

Best of JAMA Neurology 2019: Research That Drives Practice

Author Affiliations
  • 1Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York
  • 2Deputy Editor, JAMA Neurology
  • 3Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco
  • 4Associate Editor, JAMA Neurology
JAMA Neurol. 2020;77(3):293-294. doi:10.1001/jamaneurol.2019.4500

Studies published in JAMA Neurology in 2019 featured a breadth of diverse and highly influential investigations. Here, we highlight a few of many exciting studies from the past year that illustrate major strides in neurology across fields from a lens of varied experimental approaches.

Randomized clinical trials (RCTs) play a vital role in health care decision-making, so we have been particularly pleased by the increasing number of high-profile RCTs published in JAMA Neurology. Several of these in the fields of stroke, pain, and behavioral neurology promise to directly inform practice and policy—and thus quickly affect care delivery.

Add or change institution